---
figid: PMC9377080__13046_2022_2461_Fig2_HTML
figtitle: 'Diverse functions of FAT1 in cancer progression: good, bad, or ugly?'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9377080
filename: 13046_2022_2461_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9377080/figure/Fig2/
number: F2
caption: 'Major signaling pathways affected by mutated FAT1. A Wnt/β-catenin signaling
  pathway: FAT1 can bind to β-catenin. Mutated FAT1 releases β-catenin from proteasomal
  degradation complex, which enhances the nuclear translocation and transcriptional
  activity of β-catenin. B Hippo/YAP1 activation and receptor tyrosine kinase (RTK)
  signaling pathways: Mutated FAT1 releases YAP1 from Hippo complex and activates
  it as a transcription factor. Mutated FAT1 also enhances HER3 activation and IRS1
  expression, which may contribute to activation of multiple RTK signaling pathways.
  A potential link between YAP1 and ERBB signaling may be due to an autocrine loop
  through their ligand EGF and NRGs'
papertitle: 'The diverse functions of FAT1 in cancer progression: good, bad, or ugly?.'
reftext: Zhuo Georgia Chen, et al. J Exp Clin Cancer Res. 2022;41:248.
year: '2022'
doi: 10.1186/s13046-022-02461-8
journal_title: 'Journal of Experimental & Clinical Cancer Research : CR'
journal_nlm_ta: J Exp Clin Cancer Res
publisher_name: BioMed Central
keywords: FAT1 | Cancer progression | Gene mutations | Signaling regulatory network
  | Targeted treatment
automl_pathway: 0.9072335
figid_alias: PMC9377080__F2
figtype: Figure
redirect_from: /figures/PMC9377080__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9377080__13046_2022_2461_Fig2_HTML.html
  '@type': Dataset
  description: 'Major signaling pathways affected by mutated FAT1. A Wnt/β-catenin
    signaling pathway: FAT1 can bind to β-catenin. Mutated FAT1 releases β-catenin
    from proteasomal degradation complex, which enhances the nuclear translocation
    and transcriptional activity of β-catenin. B Hippo/YAP1 activation and receptor
    tyrosine kinase (RTK) signaling pathways: Mutated FAT1 releases YAP1 from Hippo
    complex and activates it as a transcription factor. Mutated FAT1 also enhances
    HER3 activation and IRS1 expression, which may contribute to activation of multiple
    RTK signaling pathways. A potential link between YAP1 and ERBB signaling may be
    due to an autocrine loop through their ligand EGF and NRGs'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LRP6
  - LRP5
  - HNF4A
  - FAT1
  - MYC
  - YAP1
  - HBEGF
  - NRG2
  - NRG1
  - NRG3
  - NRG4
  - ERBB3
  - ERBB2
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - EGF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - IGF1
  - IRS1
  - FCGR1A
  - FCGR1BP
  - FCGR1CP
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
---
